Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling.
Sign Up to like & getrecommendations! Published in 2020 at "Experimental cell research"
DOI: 10.1016/j.yexcr.2020.112091
Abstract: Methyl-CpG-binding domain 3 (MBD3), as an induced stem cells reprogramming barrier, has an abnormal expression in various prevalent malignancies. However, in pancreatic cancer cell stemness, the roles of MBD3 remain unclear. In our study, the… read more here.
Keywords: methyl cpg; pancreatic cancer; cpg binding; mbd3 ... See more keywords